Common GLP-1 medications prescribed in 2025 include: Semaglutide (Wegovy, Ozempic) Tirzepatide (Mounjaro) Liraglutide (Saxenda) Peer-reviewed clinical trials published in journals such as The New England Journal of Medicine and JAMA document average body weight reductions of approximately 1022% over 612 months when GLP-1 medications are combined with lifestyle support and ongoing physician oversight
Ingredients: Water, Butylene Glycol, Niacinamide, 1,2-Hexanediol, Zea Mays (Corn) Starch, Chondrus Crispus Extract, Chlorella Vulgaris Extract, Saccharum Officinarum (Sugarcane) Extract, Centella Asiatica Leaf Extract, Chitosan, Malus Domestica Fruit Cell Culture Extract, Polyacrylate Crosspolymer-6, Betaine, Glucose, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Tromethamine, Acetyl Glucosamine, Fructooligosaccharides, Fructose, Glycerin, Pentylene Glycol, Ethylhexylglycerin, Allantoin, Dipropylene Glycol, Adenosine, Glutathione, Madecassoside, Hydroxypropyl Methylcellulose, Hydrogenated Lecithin, Beta-Glucan, Cholesterol, Asiaticoside, Ascorbic Acid, 3-O-Ethyl Ascorbic Acid, Ascorbyl Glucoside, Ceramide NP, Tocopherol, Ferulic Acid, Lactic Acid, Disodium EDTA, Carbomer, CI 77491
Significant weight loss ( 28.3% average loss at 80 weeks)
Meanwhile, even though your Folic Acid status is great and red blood cells appear normal, not having enough B12 will cause homocysteine to build up, leading to neurological damage and changes in DNA function without you realizing it until symptoms set in
[1] In clinical studies, patients receiving clozapine plus adjunctive glycine experienced reduced antipsychotic benefit-likely owing to altered NMDA-receptor signaling
